| 1 |
34953018 | Lichen planus and lichen planopilaris flare after COVID-19 vaccination. | 2022 Mar |
1 |
| 2 |
33936047 | SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights. | 2021 |
2 |
| 3 |
34107055 | Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein. | 2021 Sep |
2 |
| 4 |
31285419 | IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes : JAKinibs suppress the interferon response in RA-FLSs. | 2019 Jul 8 |
1 |
| 5 |
30002661 | Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System. | 2018 |
1 |
| 6 |
30026273 | Calcification Induced by Type I Interferon in Human Aortic Valve Interstitial Cells Is Larger in Males and Blunted by a Janus Kinase Inhibitor. | 2018 Sep |
1 |
| 7 |
27566796 | Familial chilblain lupus due to a gain-of-function mutation in STING. | 2017 Feb |
3 |
| 8 |
27931982 | JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa. | 2017 Oct |
7 |
| 9 |
24013646 | The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells. | 2014 Dec |
2 |